Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 2
2011 2
2012 3
2013 1
2014 4
2015 5
2016 1
2017 2
2018 1
2019 1
2020 7
2021 7
2022 2
2023 3
2024 7
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms.
Marinello A, Parisi C, Vasseur D, Combarel D, Bihoreau J, Lavaud P, Ezzedine R, Zullo L, Friboulet L, Zalcman G, Italiano A, Besse B, Aldea M. Marinello A, et al. Among authors: parisi c. JTO Clin Res Rep. 2024 Nov 22;6(3):100773. doi: 10.1016/j.jtocrr.2024.100773. eCollection 2025 Mar. JTO Clin Res Rep. 2024. PMID: 39990136 Free PMC article.
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status.
De Giglio A, De Biase D, Favorito V, Maloberti T, Di Federico A, Zacchini F, Venturi G, Parisi C, Gustavo Dall'Olio F, Ricciotti I, Gagliano A, Melotti B, Sperandi F, Altimari A, Gruppioni E, Tallini G, Gelsomino F, Montanaro L, Ardizzoni A. De Giglio A, et al. Among authors: parisi c. Lung Cancer. 2025 Jan;199:108058. doi: 10.1016/j.lungcan.2024.108058. Epub 2024 Dec 20. Lung Cancer. 2025. PMID: 39709652 Free article.
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report.
De Giglio A, Zacchini F, Venturi G, Di Federico A, Parisi C, Dall'Olio FG, Ricciotti I, Favorito V, Gagliano A, De Biase D, Maloberti T, Altimari A, Gruppioni E, Tallini G, Melotti B, Sperandi F, Gelsomino F, Montanaro L, Ardizzoni A. De Giglio A, et al. Among authors: parisi c. J Liq Biopsy. 2024 Jun 21;6:100161. doi: 10.1016/j.jlb.2024.100161. eCollection 2024 Dec. J Liq Biopsy. 2024. PMID: 40027319 Free PMC article.
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience.
Parisi C, Benitez JC, Lecourt H, dall'Olio FG, Aldea M, Blanc-Durand F, Vergé V, Quivoron C, Naltet C, Abdayem P, Lavaud P, Ghigna MR, Friboulet L, Loriot Y, De Botton S, Ribrag V, Ardizzoni A, Planchard D, Soria JC, Barlesi F, Besse B. Parisi C, et al. J Liq Biopsy. 2024 Jul 30;6:100164. doi: 10.1016/j.jlb.2024.100164. eCollection 2024 Dec. J Liq Biopsy. 2024. PMID: 40027306 Free PMC article.
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review.
Mathiot L, Baldini C, Letissier O, Hollebecque A, Bahleda R, Gazzah A, Smolenschi C, Sakkal M, Danlos FX, Henon C, Beshiri K, Goldschmidt V, Parisi C, Patrikidou A, Michot JM, Marabelle A, Postel-Vinay S, Bernard-Tessier A, Loriot Y, Ponce S, Champiat S, Ouali K. Mathiot L, et al. Among authors: parisi c. Curr Oncol Rep. 2024 Oct;26(10):1236-1248. doi: 10.1007/s11912-024-01576-9. Epub 2024 Jul 27. Curr Oncol Rep. 2024. PMID: 39066847 Review.
50 results